WILMINGTON, Del., July 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12, 2025, at 11:00 a.m. Eastern Time. A live webcast and replay of the presentation will be accessible from Clover Health's investor relations website at https://investors.cloverhealth.com/. About Clover Health:Clo ...

WILMINGTON, Del., July 17, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a physician enablement company bringing access to great healthcare to everyone on Medicare, today announced the appointment of Joseph (Joe) Oldakowski as Vice President of Finance and Controller. In this role, Mr. Oldakowski reports to Chief Financial Officer Peter Kuipers and will lead Clover’s corporate accounting, GAAP, SEC, and statutory financial reporting and tax function. Mr. Oldakow ...

Core Viewpoint - Clover Health Investments, Corp. has launched a community-based pharmacy pilot program in New Jersey aimed at improving medication management for seniors and enhancing their health outcomes through local pharmacies [1][2][3] Group 1: Program Details - The pilot program is in partnership with IPC Digital Health and utilizes the iCare+ Independent Pharmacy Network, which includes thousands of community pharmacies [2] - Local pharmacies will implement innovative care tools and virtual services to assist Clover members with chronic conditions in adhering to their medication regimens and reducing hospital visits [2][3] - The program aims to leverage real-time tools powered by Clover Assistant data and AI models to monitor prescription fills and collaborate with local healthcare providers [3] Group 2: Strategic Importance - The initiative represents a new model for supporting Clover Health's members in New Jersey, focusing on community engagement and personalized care [3][4] - Clover Health emphasizes the importance of local relationships and technology in delivering healthcare that feels personal, aligning with its broader commitment to investing in New Jersey communities [4] - The partnership with IPC Digital Health is seen as a way to empower independent pharmacies to provide smarter, more connected care [4] Group 3: Company Overview - Clover Health is a physician enablement technology company focused on providing access to affordable, high-quality healthcare for Medicare beneficiaries, particularly seniors [5] - The company utilizes its Clover Assistant software platform to aggregate patient data and support clinical decision-making, aiming to improve health outcomes through early identification and management of chronic diseases [5] - Clover Health offers PPO and HMO Medicare Advantage plans and extends its data-driven technology benefits to a wider audience through its subsidiary, Counterpart Health [5]

Company Overview - Clover Health Investments, Corp. is a physician enablement technology company focused on providing access to quality healthcare for Medicare beneficiaries, particularly seniors who have historically faced challenges in accessing affordable healthcare [2] - The company utilizes its software platform, Clover Assistant, to aggregate patient data and support clinical decision-making, aiming to improve health outcomes through early identification and management of chronic diseases [2] - Clover Health offers PPO and HMO Medicare Advantage plans across several states, with a particular emphasis on its wide-network, high-choice PPO plans [2] Upcoming Financial Results - Clover Health will release its financial results for the second quarter of 2025 after market close on August 5, 2025 [1] - A conference call and webcast will be held at 5:00 p.m. Eastern Time on the same day to discuss the company's business and financial performance [1][3] - Investors can access the conference call via telephone or through a live and archived webcast available on the company's Investor Relations website [3]

Company Overview - Clover Health Investments, Corp. is a physician enablement technology company focused on providing access to quality healthcare for Medicare recipients, particularly seniors who have historically faced challenges in accessing affordable healthcare [5] - The company utilizes its software platform, Clover Assistant, to aggregate patient data and support clinical decision-making, aiming to improve health outcomes through early identification and management of chronic diseases [5] Recent Developments - Clover Health announced its inclusion in the Russell 3000® Index, effective June 30, 2025, as part of the annual reconstitution of the Russell indexes [1][2] - This inclusion is expected to enhance the company's visibility within the investment community and is seen as a significant achievement in broadening awareness and engagement [3] Market Context - The Russell 3000® Index includes the 4,000 largest US stocks ranked by total market capitalization as of April 30, 2025, and membership lasts for one year [2] - Membership in the Russell 3000® Index also grants automatic inclusion in either the large-cap Russell 1000® Index or the small-cap Russell 2000® Index, along with relevant growth and value style indexes [2] Industry Impact - The Russell indexes are widely utilized by investment managers and institutional investors, with approximately $10.6 trillion in assets benchmarked against them as of June 2024 [3] - FTSE Russell, the provider of these indexes, is recognized for its objective market capitalization and style attributes in determining membership [2][3]

LGTMs: Date: Peter K. 11/4/24 Legal (Karen / Peter R.) Andrew T. ("I" in Investor Presentation November 2024 RAPID) Input provided 11/4 Accounting Disclaimer This presentation and the accompanying oral presentation include forward-looking statements, including, without limitation, statements regarding future events and Clover Health Investments, Corp.'s ("Clover Health," "we," "our," or "us") expectations regarding positive Adjusted EBITDA, Adjusted SG&A, Insurance BER (non-GAAP measures, as defined herein) ...

Investor Presentation December 2024 Disclaimer This presentation and the accompanying oral presentation include forward-looking statements, including, without limitation, statements regarding future events and Clover Health Investments, Corp.'s ("Clover Health," "we," "our," or "us") expectations regarding positive Adjusted EBITDA, Adjusted SG&A, Insurance BER (non-GAAP measures, as defined herein), targeted revenue and MCRs, future results of operations, financial condition, guidance, market size and oppor ...

Investor Presentation May 2025 Legal LGTM (PJR) 5.13.25 via Slack Disclaimer This presentation and the accompanying oral presentation include forward-looking statements, including, without limitation, statements regarding future events and Clover Health Investments, Corp.'s ("Clover Health," "we," "our," or "us") expectations regarding Adjusted EBITDA, Adjusted Net income from continuing operations, Adjusted SG&A, Adjusted SG&A as a percentage of revenue, Insurance BER (non-GAAP measures, as defined herein) ...

Summary of Clover Health Investments (CLOV) and Aviana Healthcare Conference Calls Clover Health Investments (CLOV) Industry Overview - Focus on Medicare Advantage market with a technology-driven approach to healthcare delivery Key Financial Results - Medicare Advantage membership increased by 30% year over year [2] - Total revenues rose by 33% year over year [3] - Adjusted EBITDA surged by 279% year over year [3] - Net income increased by over 300% year over year [3] Core Business Model - Technology-first, AI-driven clinical health plan aimed at improving early disease diagnosis and treatment [3] - Utilizes a machine learning and AI-powered platform that integrates over 100 healthcare data sources [3] - Physicians are empowered with actionable insights at the point of care, leading to earlier diagnoses and better health outcomes [3][4] Clinical Outcomes - Significant reduction in hospitalization rates for congestive heart failure patients using Clover Assistant software: 18% decrease in all-cause hospitalization and 25% decrease in 30-day readmissions [5] - Achieved the highest HEDIS score for plans with over 2,000 members, indicating superior quality of care [6][7] Competitive Positioning - Differentiates from traditional Managed Care Organizations (MCOs) by being clinically focused and enabling earlier diagnosis and treatment [8][9] - No risk delegation in financial results, indicating a pure operational model [9] Growth Strategy - Aiming for 30% member growth in 2025, focusing on areas with high member concentration [11] - Cohort analysis shows a decrease in medical cost ratio (MCR) by 700 basis points from year one to year two, indicating cost efficiency [13] - Plans to expand into additional states and offer software to third-party providers [14] Market Potential - Approximately 35 million people in the Medicare Advantage market, with a shift from HMO to PPO plans [15] - Strong conviction in guidance for continued membership and revenue growth [16] Aviana Healthcare Industry Overview - Leading national provider of home care services, focusing on pediatric, adult, and geriatric care [35] Key Financial Results - Revenue expected to exceed $2.15 billion in 2025, with adjusted EBITDA over $207 million [40] - Achieved a 7.5% revenue CAGR over the last five years [39] Strategic Transformation - Five primary strategic initiatives for 2025: 1. Enhance partnerships with government and preferred payers [42] 2. Identify cost efficiencies and synergies [42] 3. Modernize medical solutions [42] 4. Manage capital structure and produce positive free cash flow [42] 5. Engage leaders and employees to deliver the mission [42] Growth and Expansion - Plans to acquire Thrive Skilled Pediatric Care, expanding footprint to 36 states [38] - Targeting organic growth of 5% to 7%, with potential for 10% growth through acquisitions [52] Financial Health - Consolidated adjusted EBITDA increased by 93.1% year over year [60] - Maintains strong liquidity of over $260 million [61] - Focused on deleveraging and maintaining a balanced capital structure [62] Market Demand - Strong demand for home and community-based care, with a focus on reducing total healthcare costs [44] - Continued advocacy for improved reimbursement rates and Medicaid rate integrity [48] Conclusion - Both Clover Health and Aviana Healthcare are positioned for significant growth in their respective markets, leveraging technology and strategic partnerships to enhance service delivery and financial performance.

Clover Health Investments, Corp. (CLOV) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and follo ...